OMEROS CORP (OMER)

Noteworthy Tuesday Option Activity: OMER, THC, HOG

Omeros Announces Webcast Details for Annual Meeting of Shareholders

Notable Monday Option Activity: OMER, AMC, DVN

Omeros Corporation Further Strengthens its Balance Sheet through Series of Financing Transactions Extending Maturity on a Majority of its Outstanding Debt into 2028

OMER Stock Earnings: Omeros Misses EPS for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Omeros (NASDAQ:OMER) just reported results for the first quarter of 2024.Omeros...

OMER Stock Earnings: Omeros Misses EPS for Q1 2024

OMER stock results show that Omeros missed analyst estimates for earnings per share the first quarter of 2024.

Omeros Corporation Reports First Quarter 2024 Financial Results

Omeros Corporation to Announce First Quarter Financial Results on May 15, 2024

Omeros Corporation Announces Upcoming Presentations at 2024 European Hematology Association (EHA) Hybrid Congress

Commit To Purchase Omeros At $2, Earn 25.2% Annualized Using Options

OMER Stock Earnings: Omeros Misses EPS for Q4 2023

OMER stock results show that Omeros missed analyst estimates for earnings per share the fourth quarter of 2023.

OMER Stock Earnings: Omeros Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Omeros (NASDAQ:OMER) just reported results for the fourth quarter of 2023.Omero...

Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results

Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024

Sleeping Giants: 3 Picks With Massive Upside by Mid-Decade

Discover three stocks with massive upside in oil and gas, data processing and outsourcing services, and pharmaceuticals sectors.

Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy

3 Sleeper Stocks Under $15 Ready to Explode by 2029

Discover 3 under-$15 stocks primed for a 2029 explosion, from fintech disruptors to biotech pioneers tackling untreatable rare diseases.

Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust

Commit To Purchase Omeros At $3, Earn 31.7% Using Options

7 Short-Squeeze Stocks That Are Screaming for Speculation

If you like to march to your own beat even against high pressure, these short-squeeze stocks could be right for you.

Omeros Corporation Reports Third Quarter 2023 Financial Results

Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2023

Omeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy

Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting

Omeros Corporation Hires Andreas Grauer M.D. as Chief Medical Officer

Notable Monday Option Activity: MARA, LRCX, OMER